Denali Therapeutics (4DN.MU) Q1 2026 Earnings

26FebConfirmed
Q1 2026
-0.62
-0.62
-0.62
-0.62

Details

Expected EPS
-0.62436214644
Actual EPS
-0.6185436
Surprise EPS
0.01
Surprise Percent
+0.93%

Description

Denali Therapeutics (4DN.MU) has reported earnings of -0.6185436 per share for Q1 2026.

0 Comments

Share your thoughts